|API SYNTHESIS & MANUFACTURING|
Cynthia A. Challener
New platform technologies, advanced modeling tools, and addressing patient needs are important developments.
read more
| DEVELOPMENT |
Martin Koeberle
The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations.
read more
| MANUFACTURING |
Christopher Harrison, Sarah Pratt, Marc Brown, PhD
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
read more
| MANUFACTURING: LYOPHILIZATION |
Felicity Thomas
Technical advances in process understanding and control must be accompanied by a change in mindset.
read more
| PEER-REVIEWED RESEARCH |
John Wasylyk, Ming Huang, Bob Wethman, Kieran O'Connor
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.
read more
| QUALITY |
Agnes Shanley
Robotic isolators and single-use technologies are gaining ground, according to aseptic processing consultant Jim Agalloco.
read more
| OPERATIONS |
Eric Bohn, Magdalena Krapf
Storage and retrieval methods and the unique requirements found in building codes are crucial considerations.
read more
| SUPPLY CHAIN |
Amber Lowry
Recent advancements in cold-chain technology offer improved transporting and storing of temperature-sensitive pharmaceutical products.
read more
| ANALYTICAL SERVICES |
Agnes Shanley
When transferring a method from R&D to quality control, success hinges on discovering where "the best" and "the most reliable" intersect.
read more
| FROM THE EDITOR |
Rita C. Peters
Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.
read more
| US REGULATORY WATCH |
Jill Wechsler
Policies emphasize the importance of ensuring data integrity in the United States and abroad.
read more
| ASK THE EXPERT |
Susan J. Schniepp
Getting to the root of the cause can prevent future problems, says Susan Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
read more
|
